SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001839882-23-012504
Filing Date
2023-05-10
Accepted
2023-05-10 17:14:39
Documents
1
Period of Report
2023-05-08

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 4362
  Complete submission text file 0001839882-23-012504.txt   5827
Mailing Address 26 MAIN STREET, SUITE 101 CHATHAM NJ 07928
Business Address 26 MAIN STREET, SUITE 101 CHATHAM NJ 07928 212-980-9155
Tonix Pharmaceuticals Holding Corp. (Issuer) CIK: 0001430306 (see all company filings)

IRS No.: 261434750 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O TONIX PHARMACEUTICALS HOLDING CORP. 509 MADISON AVE., SUITE 306 NEW YORK NY 10022
Business Address
Bell Margaret Smith (Reporting) CIK: 0001716713 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36019 | Film No.: 23907674